ECM
OPRX icon

ExodusPoint Capital Management’s OptimizeRx OPRX Stock Holding History

ExodusPoint Capital Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,252
Closed -$150K – 1949
2025
Q4 		$150K Buy
+12,252
New +$200K ﹤0.01% 1414
2024
Q2 		– Sell
-11,341
Closed -$138K – 1853
2024
Q1 		$138K Buy
+11,341
New +$164K ﹤0.01% 1402
2023
Q4 		– Sell
-97,160
Closed -$756K – 1898
2023
Q3 		$756K Buy
97,160
+78,948
+433% +$859K 0.01% 1068
2023
Q2 		$260K Buy
+18,212
New +$259K ﹤0.01% 1597
2021
Q4 		– Sell
-8,565
Closed -$733K – 2483
2021
Q3 		$733K Buy
+8,565
New +$537K 0.01% 1186

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's OPRX Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 12,252 shares — an estimated $150K sold.

ExodusPoint Capital Management first reported a position in OPRX in Q3 2021 and held it in 5 quarters. The position peaked at $756K in Q3 2023. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 12,252 OptimizeRx shares in Q1 2026, an estimated $150K.
  • ExodusPoint Capital Management first reported a position in OptimizeRx in Q3 2021 and held it in 5 quarters.
  • ExodusPoint Capital Management's OptimizeRx position peaked at $756K in Q3 2023.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.